News
CF AMR Syndicate Achieves Gold Standard from Patient Partnership Index
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has achieved the Gold Standard from the Patient Partnership Index (PPI).
The PPI is the UK’s leading initiative in patient-centric communications and advocacy. Based on best practice, it evaluates the highest standards of partnerships between pharmaceutical, biotech and patient communities.